Customers We Serve
The solutions we offer harnesses complex machine learning and AI's potential in biotechnology to conduct in-depth technical analysis, surpassing prior limitations - de-risking investor capital.
​
In typical biotech investment presentations, researchers aim to understand causal relationships between variables like molecules and tissues. However, human cognitive biases can lead to flawed hypotheses and incorrect conclusions.
Current legal and financial due diligence practices often miss the full complexity of real-world biological interactions. Consequently, despite extensive due diligence, 90% of clinical drug development fails, resulting in significant losses for investors. These failures occur because investors lack the critical insights provided by Imagine Biotech's reports.
1
Venture Capital Funds/Private Investors
Amidst waning confidence and funding challenges faced by some biotech VC funds, we add sophisticated technical due diligence services to create real value. We offer scientific reports to evaluate and mitigate investment risks by early identification of drug-protein interaction and human physiology absorption issues, enhancing decision-making efficiency and resource savings. Supporting funds as they set out to build investor confidence, and raise capital from limited partners.
2
Startups/Founders
At Imagine Biotech, we offer third-party verification of drug hypotheses or candidates to help attract risk-adjusted investor interest. By assisting with efficient resource allocation and data-driven decision-making, we leverage our team of experts to de-risk projects, enhance investor appeal, and improve project success prospects while ensuring regulatory compliance. We are also open to discussing an exchange of our services for equity in certain projects and capital raises.
3
Tech Transfer Academic Institutions
We partner with academic institution tech transfer offices to help bring their innovations to market. By providing detailed scientific analysis and commercialization strategies, we ensure patents are thoroughly evaluated and positioned as investable opportunities. Our expertise helps institutions maximize the potential of their discoveries, transforming early-stage ideas into viable, market-ready assets.
Get in touch with us through our contact form; we're here and ready to discuss possibilities in a different light.